Mifepristone Drug-Drug Interaction Study With CYP3A Inhibitor

Inclusion Criteria: * Be healthy * Have a BMI of 18 to 32 kg/m2, inclusive and body weight more than 50 kg (110 pounds) * Be judged to be in good health, based on the results of medical history, physical examination, vital signs, 12-lead ECG, and clinical laboratory findings * Have suitable veins for multiple venipuncture/cannulation Exclusion Criteria: * Have multiple drug allergies, or be allergic to any of the components of mifepristone or itraconazole * Have a condition that could be aggravated by glucocorticoid blockade (eg, asthma, any chronic inflammatory condition) * In the 1 year before study drug administration, have a history of drug or alcohol abuse * In the 6 calendar months before study drug administration, on average * Have smoked more than 5 cigarettes/day * Have consumed more than 21 units of alcohol/week (1 unit/drink = 5 ounces of wine, or 12 ounces of beer, or 1.5 ounces of hard liquor) * In 2 months prior to study drug administration, have donated/lost blood or plasma in excess of 400 mL * In the 30 days before study drug administration, have participated in another clinical trial of a new chemical entity or a prescription medicine